Company: ACHV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-268074
Chunk: 8

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 8
---
 Stockholders' equity:

     Series A convertible preferred stock, $0.001 par value, 9,158 shares designated, zeroissued and outstanding at September 30, 2025 and zero issued and outstanding at December 31, 2024

     —

     —

     Series B convertible preferred stock, $0.001 par value, 6,256 shares designated, zeroissued and outstanding at September 30, 2025 and zero issued and outstanding at December 31, 2024

     —

     —

     Common stock, $0.001 par value, 150,000,000 shares authorized, 52,812,488 issued and outstanding at September 30, 2025 and 34,685,072 issued and outstanding at December 31, 2024

     121

     103

     Additional paid-in capital

     279,049

     226,343

     Accumulated deficit

     (245,564
     )

     (205,578
     )

     Accumulated other comprehensive income

     9

     31

     Total stockholders' equity

     33,615

     20,899

     Total liabilities and stockholders' equity
      
     $
     52,040

     $
     38,633

     Going concern [note 1]

     Subsequent events [note 10]

See accompanying notes.